Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
A single-center, open-label clinical study to evaluate whether a dietary supplement can reduce hair loss in women with GLP-1-associated telogen effluvium. Participants will use the supplement for 120 days. Researchers will evaluate hair loss, hair density, and hair growth through clinical assessments, hair measurements (trichogram), and participant questionnaires.
Epistemonikos ID: fa36973eb8ba376fcb1c5ea92ef9b9ba283ecc8e
First added on: Aug 26, 2026